We have been helping patients of all ages for 85 years. We create medicines for headaches, heartaches and those used in hospitals to save lives. We also enjoy the trust of doctors and pharmacists and work with them to help ensure healthy and long life for patients.
We are a leading player on the Polish pharmaceutical market and one of the major drug manufacturers in the region of Central and Eastern Europe, Central Asia and the Caucasus. The company’s history goes back to 1935. Based on our rapid development, expansion to foreign markets and capital investments, we have become a strong multinational pharmaceutical group employing over 7,500 people and offering modern drugs, substances and innovative solutions to patients and business partners from all corners of the world. Every year, approximately 400 million packages of medicines are shipped from Polpharma Group’s factories to help people in 35 countries. Our pharmaceutical substances are exported to over 60 countries, including the highly developed markets of the United States, Japan and Korea.
We focus on quality, safety and innovation in all spheres of our activity. Based on a broad portfolio of approx. 750 products, we are able to support patients in the therapy and prevention of the most common diseases. Our fields of expertise include cardiology, neurology, ophthalmology, pulmonology, gastroenterology, and dermatology. We collaborate with scientists and constantly invest in new products and advanced technologies to provide patients with innovative therapeutic solutions, as well as give our employees access to state-of-the-art knowledge and broad development prospects. Through the Polpharma Scientific Foundation, we fund research projects in the fields of pharmacy and medicine, and award scholarships and grants to young scientists. We attach importance to corporate social responsibility, and pursue our goals while respecting social and environmental concerns and the highest ethical standards.
Our main business markets are Poland, Kazakhstan and Russia. The Polpharma Group comprises the following Polish companies: Zakłady Farmaceutyczne Polpharma SA, Polpharma Biuro Handlowe, Polfa Warszawa S.A. and Medana Pharma S.A, as well Santo (Chimpharm), which is a leading pharmaceutical company in Kazakhstan. Our strategic partners are Akrikhin in Russia and Farmaprojects in Spain.